My take on this company is they are setting up to be a malaysian based manufacturer and distributor of medical product/devices for some global majors in conjunction with their own niche product.
Why else would they build an 8 times capacity facility which would otherwise be over capitalising. Their focus is clearly asia now where the big growth low cost numbers are.
target 70c by june 30, page-9
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)